Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries said Sunday that it targets an increase of 28.6% in profits for fiscal year 2017/2018.
The company plans to achieve a net profit of EGP 82 million for FY17/18, compared to EGP 63.75 million for FY16/17.
The estimated investment budget for FY17/18 was set at EGP 10.3 million, according to a bourse filing.
Alexandria Pharmaceuticals targets EGP 620 million revenues for FY17/18, versus EGP 430 million targeted for the current fiscal year.
